PI3K/Akt/mTOR-IN-2
PI3K/Akt/mTOR-IN-2 is a selective small molecule inhibitor of the PI3K/AKT/mTOR pathway with demonstrated in vitro anticancer activity. It exhibits potent, selective cytotoxicity against MDA-MB-231 breast cancer cells (IC50 = 2.29 μM) by inducing cell cycle arrest and apoptosis, making it a useful research tool for oncology and signal transduction studies.
Product Specifications
CAS Number
2757804-89-8
Product Name Alternative
Apoptosis, Akt, mTOR, PI3K
Field of Research
Cell Biology, Signal Transduction
Purity
99.61% (May vary between batches)
Solubility
DMSO:55 mg/mL (192.79 mM)
Smiles
Fc1cc (F) cc (c1) C1OCCc2c1[nH]c1ccccc21
Molecular Formula
C17H13F2NO
Molecular Weight
285.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC743048-500 1x 500 µL
MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146 (MCAM/3048), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942008-500 1x 500 µL
IL-4 (Interleukin-4), Mouse (11B11), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0489-100 1x 100 µL
Topoisomerase (DNA) I, Mitochondrial (TOP1MT) (TOP1MT/568), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 